-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KiMRqX3AGecSabylOx1DBWvXambOG1sxQ+jNRYyXrwnmXd1/DwGo4izQKdJWmdYs LDISc0ch3SSP82kU7I/rjA== 0001021408-02-000686.txt : 20020413 0001021408-02-000686.hdr.sgml : 20020413 ACCESSION NUMBER: 0001021408-02-000686 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020114 ITEM INFORMATION: Changes in registrant's certifying accountant ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20020122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 02513548 BUSINESS ADDRESS: STREET 1: 6040 N CUTTER CIRCLE STE 317 CITY: PORTLAND STATE: OR ZIP: 97217 BUSINESS PHONE: 5032833911 MAIL ADDRESS: STREET 1: 6040 N CUTTER CIRCLE STE 317 CITY: PORTLAND STATE: OR ZIP: 97217 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 8-K 1 d8k.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2002 OXIS INTERNATIONAL, INC. (Exact name of Registrant as specified in its charter) Delaware 0-8092 94-1620407 (State or other jurisdiction (Commission File No.) (IRS Employer of incorporation) Identification No.) 6040 N. Cutter Circle, Suite 317, Portland, Oregon 97217 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (503) 283-3911 Not applicable (Former name or former address, if changed since last report) Item 4. Changes in Registrant's Certifying Accountant (a) Effective January 14, 2002, OXIS International, Inc. ("OXIS") dismissed its prior independent accountant, Deloitte & Touche LLP ("Deloitte"). The decision to change accountants was approved by the audit committee of OXIS's Board of Directors. Deloitte's independent auditors' report dated March 1, 2001 on OXIS's consolidated financial statements as of and for the years ended December 31, 2000 and 1999 appearing in OXIS's Annual Report on Form 10-K for the year ended December 31, 2000 did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles except for an explanatory paragraph relating to the Company's ability to continue as a going concern. During the audits of OXIS's consolidated financial statements as of and for the years ended December 31, 2000 and 1999 and through the subsequent interim periods to the date hereof, there were no disagreements between OXIS and Deloitte on any matters of accounting principles or practices, financial statement disclosure, or auditing scope of procedure, which disagreements, if not resolved to the satisfaction of Deloitte, would have caused it to make a reference to the subject matter of the disagreements in connection with its reports. OXIS has requested that Deloitte furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of such letter is being filed as Exhibit 16 to this Form 8-K. (b) Effective January 14, 2002, OXIS engaged King Griffin & Adamson P.C. as its principal accountant. During the last two fiscal years and the subsequent interim period to the date hereof, OXIS did not consult King Griffin & Adamson P.C. regarding any of the matters or events set forth in Item 304(a)(2)(i) and (ii) of Regulation S-K. Item 7. Financial Statements and Exhibits. (c) Exhibits. The following exhibits are filed herewith: 16. Letter addressed to the Company dated January 16, 2002 from Deloitte & Touche LLP to the Securities and Exchange Commission. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OXIS INTERNATIONAL, INC. (Registrant) Date: January 18, 2002 By: /s/ Ray R. Rogers ----------------------------- Ray R. Rogers President 2 EXHIBIT INDEX Exhibit No. Description - ----------- ----------- 16. Letter addressed to OXIS International, Inc. dated January 16, 2002 from Deloitte & Touche LLP to the Securities and Exchange Commission. 3 EX-16 3 dex16.txt LETTER DATED JANUARY 16, 2002 EXHIBIT 16 January 16, 2002 Securities and Exchange Commission Mail Stop 11-3 450 Fifth Street, NW Washington, D.C. 20549 Dear Sirs/Madams: We have read and agree with the comments in Item 4 of Form 8-K of OXIS International, Inc. dated January 14, 2002. Yours truly, /s/ DELOITTE & TOUCHE LLP -----END PRIVACY-ENHANCED MESSAGE-----